Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Recruiting1
Terminated1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT05039632Phase 1/2Recruiting
Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies
Advanced Malignant Solid NeoplasmMetastatic Malignant Neoplasm in the LiverMetastatic Malignant Neoplasm in the Lung+1 more
PrincipalinvestigatorStart date: 2023-05-08

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

Lung CancerAdvanced Malignant Solid Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score12%

Aung Naing, Md

M.D. Anderson Cancer Center

Related
16 trials

Shared therapeutic areas:

Advanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score12%

Sirilak Suksompong, MD

Mahidol University

Related
17 trials

Shared therapeutic areas:

Lung Cancer
Similarity Score6%

Heinz-Josef Lenz, MD

University of Southern California

Related
13 trials

Shared therapeutic areas:

Lung Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Lizhi Niu, PhD

Fuda Cancer Hospital

Related
31 trials

Shared therapeutic areas:

Lung Cancer
Similarity Score6%

Herui Yao, PhD

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Related
11 trials

Shared therapeutic areas:

Lung Cancer
Similarity Score6%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Lung Cancer
Similarity Score6%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Lung Cancer
Similarity Score6%

Corey J. Langer, MD

Fox Chase Cancer Center

Related
16 trials

Shared therapeutic areas:

Lung Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Lung Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT05039632Phase 1/2PrincipalInvestigator

Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies

Advanced Malignant Solid NeoplasmMetastatic Malignant Neoplasm in the LiverMetastatic Malignant Neoplasm in the Lung+1 more
Recruiting
NCT05609331Not ApplicablePrincipalInvestigator

Feasibility, Safety, and Efficacy of Stereotactic MRI-Guided Adaptive Radiation Therapy (SMART) for Central Lung Tumors

Lung Cancer
Terminated

All 2 trials loaded